These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9884355)

  • 1. Periarticular bone alterations in chronic antigen-induced arthritis: free and liposome-encapsulated clodronate prevent loss of bone mass in the secondary spongiosa.
    Oelzner P; Bräuer R; Henzgen S; Thoss K; Wünsche B; Hersmann G; Abendroth K; Kinne RW
    Clin Immunol; 1999 Jan; 90(1):79-88. PubMed ID: 9884355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteoprotegerin reduces the loss of periarticular bone mass in primary and secondary spongiosa but does not influence inflammation in rat antigen-induced arthritis.
    Neumann T; Oelzner P; Petrow PK; Thoss K; Hein G; Stein G; Bräuer R
    Inflamm Res; 2006 Jan; 55(1):32-9. PubMed ID: 16429254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose clodronate therapy prevents joint destruction in chronic antigen-induced arthritis of the rat but inhibits bone formation at the axial skeleton.
    Oelzner P; Kunze A; Henzgen S; Thoss K; Hein G; Stein G; Bräuer R
    Inflamm Res; 2000 Aug; 49(8):424-33. PubMed ID: 11028760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of clodronate in the bone of adult rats and its effects on trabecular and cortical bone.
    Osterman T; Virtamo T; Kippo K; Laurén L; Pasanen I; Hannuniemi R; Sellman R
    J Pharmacol Exp Ther; 1997 Feb; 280(2):1051-6. PubMed ID: 9023323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory effect of antidiabetic thiazolidinediones prevents bone resorption rather than cartilage changes in experimental polyarthritis.
    Koufany M; Moulin D; Bianchi A; Muresan M; Sebillaud S; Netter P; Weryha G; Jouzeau JY
    Arthritis Res Ther; 2008; 10(1):R6. PubMed ID: 18199331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta, gamma-dichloromethylene) triphosphate, by mammalian cells in vitro.
    Frith JC; Mönkkönen J; Blackburn GM; Russell RG; Rogers MJ
    J Bone Miner Res; 1997 Sep; 12(9):1358-67. PubMed ID: 9286751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Slow-release clodronate in prevention of inflammation and bone loss associated with adjuvant arthritis.
    Osterman T; Virtamo T; Laurén L; Kippo K; Pasanen I; Hannuniemi R; Väänänen K; Sellman R
    J Pharmacol Exp Ther; 1997 Feb; 280(2):1001-7. PubMed ID: 9023317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Damaging effects of chronic low-dose methotrexate usage on primary bone formation in young rats and potential protective effects of folinic acid supplementary treatment.
    Fan C; Cool JC; Scherer MA; Foster BK; Shandala T; Tapp H; Xian CJ
    Bone; 2009 Jan; 44(1):61-70. PubMed ID: 18976724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of clodronate on immobilization bone loss.
    Minaire P; Depassio J; Berard E; Meunier PJ; Edouard C; Pilonchery G; Goedert G
    Bone; 1987; 8 Suppl 1():S63-8. PubMed ID: 2961357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone protective effect of simvastatin in experimental arthritis.
    Funk JL; Chen J; Downey KJ; Clark RA
    J Rheumatol; 2008 Jun; 35(6):1083-91. PubMed ID: 18464303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,25-Dihydroxyvitamin D3 prevents bone loss of the secondary spongiosa in arthritic rats by an increase of bone formation and mineralization and inhibition of bone resorption.
    Oelzner P; Petrow PK; Wolf G; Bräuer R
    BMC Musculoskelet Disord; 2014 Oct; 15():345. PubMed ID: 25315028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisphosphonate effects in rat unloaded hindlimb bone loss model: three-dimensional microcomputed tomographic, histomorphometric, and densitometric analyses.
    Barou O; Lafage-Proust MH; Martel C; Thomas T; Tirode F; Laroche N; Barbier A; Alexandre C; Vico L
    J Pharmacol Exp Ther; 1999 Oct; 291(1):321-8. PubMed ID: 10490920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pamidronate prevents bone loss associated with carrageenan arthritis by reducing resorptive activity but not recruitment of osteoclasts.
    Moran EL; Fornasier TL; Bogoch TR
    J Orthop Res; 2000 Nov; 18(6):873-81. PubMed ID: 11192246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clodronate stimulates bone formation as well as inhibits bone resorption and increases bone mineral density in rats fed a low-calcium diet.
    Horie D; Takahashi M; Aoki K; Ohya K
    J Med Dent Sci; 2003 Mar; 50(1):121-32. PubMed ID: 12715928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FR177995, a novel vacuolar ATPase inhibitor, exerts not only an inhibitory effect on bone destruction but also anti-immunoinflammatory effects in adjuvant-induced arthritic rats.
    Niikura K; Nakajima S; Takano M; Yamazaki H
    Bone; 2007 Apr; 40(4):888-94. PubMed ID: 17157574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of instability-induced bone resorption using bisphosphonates: high doses are needed in rats.
    Astrand J; Aspenberg P
    Acta Orthop Scand; 2002 Jan; 73(1):24-30. PubMed ID: 11928907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular mechanism of action of the antiresorptive and antiinflammatory drug clodronate: evidence for the formation in vivo of a metabolite that inhibits bone resorption and causes osteoclast and macrophage apoptosis.
    Frith JC; Mönkkönen J; Auriola S; Mönkkönen H; Rogers MJ
    Arthritis Rheum; 2001 Sep; 44(9):2201-10. PubMed ID: 11592386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A trial of clodronate-liposomes as anti-macrophage treatment in a sheep model of arthritis.
    Highton J; Guévremont D; Thomson J; Carlisle B; Tucker I
    Clin Exp Rheumatol; 1999; 17(1):43-8. PubMed ID: 10084031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disodium clodronate in painful nonresponsive periarthropathy of the hip.
    Monteforte P; Molfetta L; Grillo G; Brignone A; Rovetta G
    Int J Tissue React; 2000; 22(4):111-5. PubMed ID: 11199340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with dexamethasone and osteoprotegerin protects against arthritis-induced bone alterations in antigen-induced arthritis of the rat.
    Oelzner P; Fleissner-Richter S; Bräuer R; Hein G; Wolf G; Neumann T
    Inflamm Res; 2010 Sep; 59(9):731-41. PubMed ID: 20306217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.